| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Palifosfamide |
➤ Sign Up |
Formulations and methods of reducing toxicity of antineoplastic agents |
BioNumerik Pharmaceuticals, Inc. (San Antonio, TX) |
➤ Sign Up |
| Palifosfamide |
➤ Sign Up |
Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
DEKK-TEC, Inc. (New Orleans, LA) |
➤ Sign Up |
| Palifosfamide |
➤ Sign Up |
Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
Ziopharm Oncology, Inc. (Boston, MA) |
➤ Sign Up |
| Palifosfamide |
➤ Sign Up |
Phosphoramidate alkylator prodrugs |
Threshold Pharmaceuticals, Inc. (Redwood CIty, CA) |
➤ Sign Up |
| Palifosfamide |
➤ Sign Up |
Salts of isophosphoramide mustard and analogs thereof as anti-tumor Agents |
DEKK-TEC, Inc. (New Orleans, LA) |
➤ Sign Up |
| Palifosfamide |
➤ Sign Up |
Treatment or prophylaxis of proliferative conditions |
The University of the University of Dundee (Dundee, GB) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
